Tianyu Zhang
zhang_tianyu@gibh.ac.cn
Chinese, English
Guangdong
University of Chinese Academy of Sciences
Medical School
  • 2002-08--2005-07 PhD: Chinese Academy of Medical Sciences and Peking Union Medical College
  • 1999-09--2002-07 Master's: Capital Normal University, School of Life Sciences
  • 1995-09--1999-07 Bachelor's: Capital Normal University, School of Life Sciences
  • 2024.04-present - Guangzhou Medical University - Distinguished Mentor
  • 2022.03-present - Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences - Researcher
  • 2021.08-present - China-New Zealand Joint Laboratory for Biomedicine and Health - Researcher
  • 2021.06-present - Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences - Visiting Professor
  • 2021.06-present - Key Laboratory of Quality Research and Evaluation of In Vitro Diagnostic Reagents, National Medical Products Administration - Researcher
  • 2021.05-present - Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences - Deputy Director
  • 2019.12-present - Guangdong-Hong Kong-Macao Joint Laboratory for Respiratory Infectious Diseases - Researcher
  • 2018.08-present - National Key Laboratory of Respiratory Diseases - Group Leader
  • 2018.01-present - Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences - Key Cultivation Direction Leader
  • 2017.09-present - Guangzhou Chest Hospital - Visiting Professor
  • 2016.09-present - School of Medicine, University of Chinese Academy of Sciences - Professor
  • 2012.01-present - National Key Laboratory of Respiratory Diseases - Co-Director
  • 2011.01-present - National Key Laboratory of Respiratory Diseases - Researcher
  • 2010.09-present - Anhui University - Professor
  • 2010.09-present - University of Science and Technology of China - Professor
  • 2010.09-present - Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences - Researcher
  • Guangzhou Education Base Outstanding Graduate Supervisor (2023)
  • Guangzhou Huangpu District Innovation and Entrepreneurship Leading Talent (2022)
  • China Invention Association Invention and Entrepreneurship Award Innovation Award Second Prize (2021)
  • University of Chinese Academy of Sciences Education Foundation Excellent Educator in Life Sciences (2021)
  • Guangzhou Huangpu District Outstanding Talent
  • Guangzhou Branch of Chinese Academy of Sciences Excellent Communist Party Member (2017-2021)
  • China Industry-University-Research Cooperation Promotion Association Innovation Award (2020)
  • National 'Ten Thousand Talents Plan' Leading Talent in Scientific and Technological Innovation (2020)
  • Ministry of Science and Technology Innovation Talent Promotion Plan Young and Middle-aged Leading Talent in Scientific and Technological Innovation (2019)
  • Guangzhou Outstanding Expert (2019)
  • Guangzhou Huangpu District Outstanding Talent (2019)
  • Guangdong Province Fifth Patent Award 'Excellence Award' (2018)
  • Guangdong Special Support Plan Leading Talent in Scientific and Technological Innovation (2016)
  • Chinese Academy of Sciences '****' A Class (2012)
Establishing new drug screening evaluation models and studying drug mechanisms of action
Developing rapid clinical diagnostic techniques for live bacterial infections and drug sensitivity testing
Developing new therapeutic vaccines and new biological therapies
Synthetic biology research related to the diagnosis and treatment of pathogenic bacteria
Development of related scientific research instruments and equipment
  • Novel derivatives of quinoxaline-2-carboxylic acid 1,4-dioxides as antimycobacterial agents: mechanistic studies and therapeutic potential, Tianyu Zhang, 2024
  • Distribution of common and rare drug resistance patterns in Mycobacterium tuberculosis clinical isolates revealed by GenoType MTBDRplus and MTBDRsl assay, Tianyu Zhang, 2024
  • Bactericidal and Sterilizing Efficacy of Sudapyridine-Clofazimine-TB47 Combined with Linezolid, and/or Pyrazinamide in a Murine Model of Tuberculosis, Tianyu Zhang, 2024
  • Synthesis and Biological Evaluation of 2-(Tetrazol-5-yl)sulfonylacetamides as Inhibitors of Mycobacterium tuberculosis, Tianyu Zhang, 2024
  • EmbB and EmbC Regulate the Sensitivity of Mycobacterium abscessus to Echinomycin, Tianyu Zhang, 2024
  • Molecular mechanisms of resistance and treatment efficacy of clofazimine and bedaquiline against Mycobacterium tuberculosis, Tianyu Zhang, 2024
  • Efficient Mutasynthesis of “Non-Natural” Antitubercular Ilamycins with Low Cytotoxicity, Tianyu Zhang, 2024
  • 3-Methoxy-2-phenylimidazo[1,2-b]pyridazines Highly Active Against Mycobacterium tuberculosis and Mycobacterium marinum, Tianyu Zhang, 2024
  • Preclinical evaluation of the SARS-CoV-2 Mpro inhibitor RAY1216 shows improved pharmacokinetics compared with nirmatrelvir, Tianyu Zhang, 2024
  • Indole propionic acid is an effective substrate for tryptophanyl-tRNA synthetase in Mycobacterium tuberculosis, Tianyu Zhang, 2024
  • Amino acid 17 in QRDR of Gyrase A plays a key role in fluoroquinolones susceptibility in Mycobacteria, Tianyu Zhang, 2024
  • Iterative Methylation Leads to 3-Methylchuangxinmycin Production in Actinoplanes tsinanensis CPCC 200056, Tianyu Zhang, 2023
  • A recombinant Mycobacterium smegmatis-based surface display system for developing the T cell-based COVID-19 vaccine, Tianyu Zhang, 2023
  • Comparative genome analysis reveals high-level drug resistance markers in a clinical isolate of Mycobacterium fortuitum subsp. fortuitum MF GZ001, Tianyu Zhang, 2023
  • Structure-Activity Relationship of Novel Pyrimidine Derivatives with Potent Inhibitory Activities against Mycobacterium tuberculosis, Tianyu Zhang, 2023
  • Expanding the Chemical Diversity of Grisechelins via Heterologous Expression, Tianyu Zhang, 2023
  • Discovery of N-(1-(6-oxo-1,6-dihydropyrimidine)-pyrazole) acetamide derivatives as novel noncovalent DprE1 inhibitors against Mycobacterium tuberculosis, Tianyu Zhang, 2023
  • Expanding structural diversity of 5′-aminouridine moiety of sansanmycin via mutational biosynthesis, Tianyu Zhang, 2023
Drug Screening Evaluation Models Drug Mechanisms Clinical Diagnostics Bacterial Infections Drug Sensitivity Therapeutic Vaccines Biological Therapies Synthetic Biology Research Instruments

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.